AI and HPV Testing: A New Approach to Cervical Cancer Detection in Low-Resource Settings

Just now November 4, 2026 1 min read 📰 Medical Xpress

📋 Key Takeaway

A study led by the Barcelona Institute for Global Health has demonstrated that combining HPV testing with AI-based image analysis can effectively detect precancerous lesions and inform treatment decisions. This research, part of the PAVE Consortium, is relevant for low-resource settings, including Iran, where cervical cancer screening may be limited. Improved detection methods could enhance women's health outcomes in the country.

Combining HPV testing with artificial intelligence–based image analysis has shown efficacy in detecting precancerous lesions and guiding treatment decisions, according to a study led by the Barcelona Institute for Global Health (ISGlobal). The research, conducted within the HPV-Automated Visual Evaluation (PAVE) Consortium across nine countries, has been published in The Lancet Obstetrics, Gynaecology & Women's Health.